510(k) device
WavelinQ Plus EndoAVF System
C.R. Bard, Inc. · Percutaneous Catheter For Creation Of An Arteriovenous Fistula For Hemodialysis Access (PQK, Class II) · First FDA decision Oct 17, 2019, newest Oct 17, 2019Kidney failure and dialysisVascular access
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
1
Naming "WavelinQ Plus EndoAVF"
MAUDE reports
0
Brand "WavelinQ Plus EndoAVF", since 2015
PubMed studies
0
Mentioning "WavelinQ Plus EndoAVF"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing WavelinQ Plus EndoAVF System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K192239 · Decided Oct 17, 2019 · 59 days after receipt
Device type: Percutaneous Catheter For Creation Of An Arteriovenous Fistula For Hemodialysis Access (PQK) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Non-Invasive Peripheral Venous Vascular and Hemodialysis Access StudiesLocal determinationIn effectL35751WPS Insurance CorporationUpdated Feb 20, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "WavelinQ Plus EndoAVF", any status and sponsor, newest update first.
- Comparing Surgical and Endovascular Arteriovenous Fistula CreationActive, not recruiting
University of California, Los AngelesAcademic, hospital or other
NCT05654103 · 90 participants (planned) · Start Nov 20, 2024 · Primary completion Oct 2026
Device: endoAVF · For: End Stage Renal Disease on Dialysis
Sites: Los Angeles, California; Pittsburgh, Pennsylvania
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "WavelinQ Plus EndoAVF", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code PQK
492 reports: 273 malfunction, 212 injury, 7 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2085-2014 · Started Jun 13, 2014 · Posted by FDA Jul 21, 2014
Reason given: Partial loss of monitoring with the CARESCAPE Monitor B850, B650 or B450. When connecting the PDM (Patient Data Module) to the CARESCAPE B850, B650 or B450 monitor with software version 2 the PDM may not start communicating to the monitor and loss of the PDM parameters could occur.
Cause as FDA categorized it: Software design · Device type: Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms) (MHX)
Published research
The most relevant PubMed records for "WavelinQ Plus EndoAVF"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code PQK.
- Ellipsys Vascular Access System (Ellipsys System)Avenu Medical · De Novo 2019
- WavelinQ 4F EndoAVF SystemC.R. Bard, Inc. · 510(k) 2019
- everlinQ endoAVF SystemTva Medical, Inc. · De Novo 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.